
PB 19 of 2026
National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2026 (No. 2)
National Health Act 1953
I, REBECCA RICHARDSON, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 98C(1) of the National Health Act 1953.
Dated 26 February 2026
REBECCA RICHARDSON
Assistant Secretary
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division
Contents
1. Name
2. Commencement
3. Authority
4. Schedules
Schedule 1—Amendments
National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019)
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 March 2026 | 1 March 2026 |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
[1] Schedule 4, after entry for Apremilast
insert:
Aripiprazole | Powder for injection 300 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe |
Aripiprazole | Powder for injection 400 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe |
[2] Schedule 4, after entry for Hypromellose with dextran
insert:
IncobotulinumtoxinA | Lyophilised powder for injection 100 units |
[3] Schedule 4, after entry for Pimecrolimus
insert:
Pioglitazone | Tablet 15 mg (as hydrochloride), pack of 30 |
Pioglitazone | Tablet 30 mg (as hydrochloride), pack of 30 |
Pioglitazone | Tablet 45 mg (as hydrochloride), pack of 30 |